| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/28/2011 | CA2786952A1 Pharmaceutical formulation for proteins |
| 07/28/2011 | CA2786212A1 Cancer stem cell markers and uses thereof |
| 07/28/2011 | CA2786149A1 Inhibition of axl signaling in anti-metastatic therapy |
| 07/28/2011 | CA2785971A1 Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof |
| 07/28/2011 | CA2785907A1 Ron binding constructs and methods of use thereof |
| 07/28/2011 | CA2785723A1 Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereof |
| 07/28/2011 | CA2785661A1 Polypeptide heterodimers and uses thereof |
| 07/28/2011 | CA2785653A1 Recombinant ndv antigen and uses thereof |
| 07/28/2011 | CA2784814A1 Heterodimer binding proteins and uses thereof |
| 07/28/2011 | CA2781733A1 Delivery system for diagnostic and therapeutic agents |
| 07/28/2011 | CA2729484A1 Film-form preparation |
| 07/27/2011 | EP2348135A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 07/27/2011 | EP2348112A2 Stabilized immune modulatory RNA (SIMRA) compounds |
| 07/27/2011 | EP2348052A2 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 07/27/2011 | EP2348051A2 CD20 antibodies with increased fc receptor binding affinity and effector function |
| 07/27/2011 | EP2348050A1 Anti-glycated CD59 antibodies and uses thereof |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348045A1 Receptor, use of same and murine antibody |
| 07/27/2011 | EP2348042A1 Modified amyloid beta peptide |
| 07/27/2011 | EP2348040A1 Replikin peptides and uses thereof |
| 07/27/2011 | EP2348036A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348035A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348034A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2347768A1 Novel use application of sugar chain-recognizing receptor |
| 07/27/2011 | EP2347767A2 Immune regulation based on the targeting of early activation molecules |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347765A1 Methods of diagnosing and treating complications of pregnancy |
| 07/27/2011 | EP2347764A2 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 07/27/2011 | EP2347757A1 A natural allicin tablet and preparation method thereof |
| 07/27/2011 | EP2346994A2 Non-human mammals for the production of chimeric antibodies |
| 07/27/2011 | EP2346990A1 Live, attentuated respiratory syncytial virus |
| 07/27/2011 | EP2346904A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 07/27/2011 | EP2346903A1 Treatment with anti-alpha2 integrin antibodies |
| 07/27/2011 | EP2346563A1 Phase-transition polymeric microneedles |
| 07/27/2011 | EP2346531A2 Tumor vaccine |
| 07/27/2011 | EP2346529A1 Human m2e peptide immunogens |
| 07/27/2011 | EP2346528A1 Nicotine immunonanotherapeutics |
| 07/27/2011 | EP2346523A2 A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 07/27/2011 | EP1960428B1 Antibodies against amyloid beta with glycosylation in the variable region |
| 07/27/2011 | EP1817061B1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 07/27/2011 | EP1633396B1 Cd20 binding molecules |
| 07/27/2011 | EP1631590B1 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 07/27/2011 | EP1594543B1 Immunogene adherence inhibitor and method of making and using the same |
| 07/27/2011 | EP1587550B1 Methods and compositions for administering therapeutic and diagnostic agents |
| 07/27/2011 | EP1578439B1 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 07/27/2011 | EP1569690B1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 07/27/2011 | EP1558645B1 Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| 07/27/2011 | EP1534284B1 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 07/27/2011 | EP1509244B1 New method and composition for producing a cellular allogeneic vaccine |
| 07/27/2011 | EP1461300B1 Antibodies against monocyte chemotactic proteins |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1278823B1 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/27/2011 | EP0904395B2 Herpes simplex virus strains |
| 07/27/2011 | CN1966684B Construction of HER2/neu mRNA in vitro transcription vector and use thereof |
| 07/27/2011 | CN102137929A Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 07/27/2011 | CN102137873A Anti-CD5 antibodies |
| 07/27/2011 | CN102137872A Cross-reactive and bispecific anti-IL 17A/F antibodies |
| 07/27/2011 | CN102137870A Antibody directed against PcrV |
| 07/27/2011 | CN102137868A Prophylactic or therapeutic agent for influenza virus infection |
| 07/27/2011 | CN102137681A Anti-pancreatic cancer antibodies |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134562A Construction and screening of rabies virus Evelyn-Rokitnicki-Abelseth (ERA) attenuated live vaccine candidate strain |
| 07/27/2011 | CN102134279A Fusion protein and encoding gene thereof as well as application of fusion protein |
| 07/27/2011 | CN102134278A Preparation of subunit vaccine for mucosal immune in circovirus genetic engineering and application thereof |
| 07/27/2011 | CN102134277A Soluble VEGFR (Vascular Endothelial Growth Factor Receptor) difunctional chimera receptor VEGFR31-Ig as well as preparation method and application thereof |
| 07/27/2011 | CN102134275A 表皮生长因子受体变异体 Epidermal growth factor receptor variant |
| 07/27/2011 | CN102133407A Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 07/27/2011 | CN102133403A Combined therapy for suppressing tumor growth by using vascular endothelial growth factor (VEGF) receptor antagonist |
| 07/27/2011 | CN102133401A Method for preparing inactivated vaccine by using double adjuvant |
| 07/27/2011 | CN102133400A Method for removing split agent in vaccine preparation process |
| 07/27/2011 | CN102133399A Novel process for preparing influenza virus split vaccine |
| 07/27/2011 | CN102133398A Method for industrially producing animal influenza vaccine by using bioreactor |
| 07/27/2011 | CN102133397A Oncotherapy type heparanase MAP vaccine |
| 07/27/2011 | CN102133396A Vaccine injection and preparation method thereof |
| 07/27/2011 | CN101696239B Human oocyte zona pellucida protein multi-epitope chimeric peptide antigen and preparation method thereof |
| 07/27/2011 | CN101690821B Immune protective agent of attenuated living vaccine against infectious bursal disease and preparation method thereof |
| 07/27/2011 | CN101690813B Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof |
| 07/27/2011 | CN101670115B Compound of heparanase and heat shock protein, preparation method and applications thereof |
| 07/27/2011 | CN101623503B Composite of survivin and sialylLewis and preparation method and application thereof |
| 07/27/2011 | CN101538328B Humanized neutralizing engineered antibody for targeting avian influenza virus H5N1 |
| 07/27/2011 | CN101513527B Bivalent inactivated vaccine against gosling plague and goose paramyxovirus disease and preparation method thereof |
| 07/27/2011 | CN101507814B Multi-component antigen acellular pertussis vaccine and preparation method thereof |
| 07/27/2011 | CN101474246B Pharmaceutical composition for enhancing immunity of fowl and coordinating with vaccine for synergy |
| 07/27/2011 | CN101440130B Variable regions of heavy chain and light chain of antihuman IL-13R alpha 2 monoclonal antibody |
| 07/27/2011 | CN101402674B Functional peptide segment of epididymis protease inhibitors and uses thereof |
| 07/27/2011 | CN101402666B Saponin with immunoadjuvant function, preparation method, vaccine preparation containing the saponin as adjuvant and uses thereof |
| 07/27/2011 | CN101367876B Monoclonal antiidiotypic antibody NP30 single-specificity double-chain antibody of Japanese blood fluke, preparation method and uses thereof |
| 07/27/2011 | CN101357227B Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 07/27/2011 | CN101352570B Diploid cell rabies vaccine and method for preparing purified rabies vaccine |
| 07/27/2011 | CN101352569B Diploid somatic cell encephalitis B vaccine and method for preparing purified encephalitis B vaccine |
| 07/27/2011 | CN101198352B C. perfringens alpha toxoid vaccine |
| 07/27/2011 | CN101094687B Nutritional composition comprising immunoglobulin and oligosaccharides |
| 07/27/2011 | CN101062949B Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof |
| 07/27/2011 | CN101018567B Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 07/27/2011 | CN101010427B Anti-A33 antibody |
| 07/26/2011 | US7985891 Immunization of fish with plant-expressed recombinant proteins |
| 07/26/2011 | US7985844 Antibody that specifically binds hyaluronan synthase |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |
| 07/26/2011 | US7985831 Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease |